Michael Rissler

497 total citations
13 papers, 297 citations indexed

About

Michael Rissler is a scholar working on Rheumatology, Immunology and Dermatology. According to data from OpenAlex, Michael Rissler has authored 13 papers receiving a total of 297 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Rheumatology, 10 papers in Immunology and 3 papers in Dermatology. Recurrent topics in Michael Rissler's work include Spondyloarthritis Studies and Treatments (11 papers), Psoriasis: Treatment and Pathogenesis (10 papers) and Rheumatoid Arthritis Research and Therapies (8 papers). Michael Rissler is often cited by papers focused on Spondyloarthritis Studies and Treatments (11 papers), Psoriasis: Treatment and Pathogenesis (10 papers) and Rheumatoid Arthritis Research and Therapies (8 papers). Michael Rissler collaborates with scholars based in Switzerland, Germany and United Kingdom. Michael Rissler's co-authors include R. Orsenigo, Christian Sieder, Effie Pournara, Chiara Perella, Ulrich Mrowietz, Laura C. Coates, Xenofon Baraliakos, Sławomir Jeka, Laure Gossec and Barbara Schulz and has published in prestigious journals such as Annals of the Rheumatic Diseases, Journal of the American Academy of Dermatology and British Journal of Dermatology.

In The Last Decade

Michael Rissler

13 papers receiving 290 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Rissler Switzerland 7 253 166 106 87 45 13 297
Soyi Liu Leage United States 7 345 1.4× 292 1.8× 94 0.9× 155 1.8× 24 0.5× 23 407
M. Sevrain France 7 313 1.2× 249 1.5× 103 1.0× 133 1.5× 25 0.6× 10 387
Ellen Frankel United States 7 217 0.9× 79 0.5× 103 1.0× 65 0.7× 32 0.7× 11 246
Maximilian Reinhardt Germany 10 184 0.7× 115 0.7× 136 1.3× 23 0.3× 78 1.7× 18 301
Susumu Kitamura Japan 6 146 0.6× 63 0.4× 132 1.2× 40 0.5× 26 0.6× 6 220
Catia De Felice Italy 10 144 0.6× 56 0.3× 133 1.3× 35 0.4× 32 0.7× 17 231
P. Regnault United States 5 307 1.2× 54 0.3× 204 1.9× 43 0.5× 86 1.9× 7 327
A. Galluccio Italy 9 188 0.7× 64 0.4× 153 1.4× 26 0.3× 29 0.6× 11 265
Ofir Elalouf Israel 7 125 0.5× 170 1.0× 30 0.3× 80 0.9× 11 0.2× 23 232
Cristina Mugheddu Italy 9 116 0.5× 46 0.3× 84 0.8× 19 0.2× 25 0.6× 22 200

Countries citing papers authored by Michael Rissler

Since Specialization
Citations

This map shows the geographic impact of Michael Rissler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Rissler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Rissler more than expected).

Fields of papers citing papers by Michael Rissler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Rissler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Rissler. The network helps show where Michael Rissler may publish in the future.

Co-authorship network of co-authors of Michael Rissler

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Rissler. A scholar is included among the top collaborators of Michael Rissler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Rissler. Michael Rissler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Gottlieb, Alice B., Xenofon Baraliakos, Laura C. Coates, et al.. (2021). 25851 Efficacy of secukinumab in managing axial manifestations and nail psoriasis in patients with psoriatic arthritis: Results from the MAXIMISE trial. Journal of the American Academy of Dermatology. 85(3). AB72–AB72. 1 indexed citations
2.
Poddubnyy, Denis, Effie Pournara, Asta Baranauskaitė, et al.. (2021). Rapid improvement in spinal pain in patients with axial spondyloarthritis treated with secukinumab: primary results from a randomized controlled phase-IIIb trial. Therapeutic Advances in Musculoskeletal Disease. 13. 1759720X211051471–1759720X211051471. 5 indexed citations
3.
Baraliakos, Xenofon, Laure Gossec, Effie Pournara, et al.. (2021). P184 Secukinumab provides sustained improvements in clinical and imaging outcomes in patients with psoriatic arthritis and axial manifestations: results from the MAXIMISE trial. Lara D. Veeken. 60(Supplement_1). 1 indexed citations
4.
5.
Baraliakos, Xenofon, Laure Gossec, Effie Pournara, et al.. (2020). Secukinumab in patients with psoriatic arthritis and axial manifestations: results from the double-blind, randomised, phase 3 MAXIMISE trial. Annals of the Rheumatic Diseases. 80(5). 582–590. 110 indexed citations
6.
Poddubnyy, Denis, Effie Pournara, Agnieszka Zielińska, et al.. (2020). AB0659 SECUKINUMAB PROVIDES SIGNIFICANT IMPROVEMENT OF SPINAL PAIN IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS: RESULTS FROM THE 24-WEEK PHASE 3 SKIPPAIN STUDY. Annals of the Rheumatic Diseases. 79. 1624–1625. 1 indexed citations
7.
Baraliakos, Xenofon, Laure Gossec, Effie Pournara, et al.. (2020). OP0053 SECUKINUMAB IMPROVES CLINICAL AND IMAGING OUTCOMES IN PATIENTS WITH PSORIATIC ARTHRITIS AND AXIAL MANIFESTATIONS WITH INADEQUATE RESPONSE TO NSAIDS: WEEK 52 RESULTS FROM THE MAXIMISE TRIAL. Annals of the Rheumatic Diseases. 79. 35–36. 7 indexed citations
8.
Augustin, Matthias, E. Daudén, Ulrich Mrowietz, et al.. (2020). Baseline characteristics of patients with moderate‐to‐severe psoriasis according to previous systemic treatment exposure: the PROSE study population. Journal of the European Academy of Dermatology and Venereology. 34(11). 2548–2556. 9 indexed citations
9.
Augustin, Matthias, E. Daudén, Ulrich Mrowietz, et al.. (2020). Secukinumab treatment leads to normalization of quality of life and disease symptoms in psoriasis patients with or without prior systemic psoriasis therapy: the PROSE study results. Journal of the European Academy of Dermatology and Venereology. 35(2). 431–440. 18 indexed citations
10.
Mrowietz, Ulrich, H. Bachelez, A. David Burden, et al.. (2019). Secukinumab for moderate-to-severe palmoplantar pustular psoriasis: Results of the 2PRECISE study. Journal of the American Academy of Dermatology. 80(5). 1344–1352. 81 indexed citations
11.
Choy, Ernest, Xenofon Baraliakos, Frank Behrens, et al.. (2019). The need for comparative data in spondyloarthritis. Arthritis Research & Therapy. 21(1). 32–32. 6 indexed citations
12.
Baraliakos, Xenofon, Laura C. Coates, Laure Gossec, et al.. (2019). OP0235 SECUKINUMAB IMPROVES AXIAL MANIFESTATIONS IN PATIENTS WITH PSORIATIC ARTHRITIS AND INADEQUATE RESPONSE TO NSAIDS: PRIMARY ANALYSIS OF THE MAXIMISE TRIAL. Annals of the Rheumatic Diseases. 78. 195–196. 19 indexed citations
13.
Reich, Kristian, L. Puig, Jacek C. Szepietowski, et al.. (2019). Secukinumab dosing optimization in patients with moderate‐to‐severe plaque psoriasis: results from the randomized, open‐label OPTIMISE study. British Journal of Dermatology. 182(2). 304–315. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Soyi Liu Leage Breakdown of academic impact, for papers by M. Sevrain Breakdown of academic impact, for papers by Ellen Frankel Breakdown of academic impact, for papers by Maximilian Reinhardt Breakdown of academic impact, for papers by Susumu Kitamura Breakdown of academic impact, for papers by Catia De Felice Breakdown of academic impact, for papers by P. Regnault Breakdown of academic impact, for papers by A. Galluccio Breakdown of academic impact, for papers by Ofir Elalouf Breakdown of academic impact, for papers by Cristina Mugheddu
Rankless by CCL
2026